Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07235501 · ClinicalTrials.gov registry record
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
A clinical trial, sponsored by City of Hope Medical Center.
- Not yet
- Registry status
- 75
- Enrollment target
NCT07235501 is a clinical trial that has not yet begun recruiting, run by City of Hope Medical Center. The registered enrollment target is 75 participants.
The verdict
NCT07235501 has not yet begun recruiting, sponsored by City of Hope Medical Center.
- NOT YET RECRUITING
- Registry status
- 75 participants
- Enrollment target
Study Summary
This study evaluates the factors that contribute to chronic graft-versus-host disease, which is a complication that can occur after allogeneic hematopoietic cell transplantation.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-04-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07235501
The ClinicalTrials.gov registry entry for NCT07235501 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07235501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07235501 about?
NCT07235501 is a clinical study titled "Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation". This study evaluates the factors that contribute to chronic graft-versus-host disease, which is a complication that can occur after allogeneic hematopoietic cell transplantation.
What is the current status of trial NCT07235501?
This trial is currently not yet recruiting. The enrollment target is 75 participants. The study started on 2026-06-01. Estimated completion is 2028-04-11.
What interventions are being tested in trial NCT07235501?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07235501?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.